Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
18.46
-0.25 (-1.34%)
At close: Mar 28, 2025, 4:00 PM
18.07
-0.39 (-2.11%)
After-hours: Mar 28, 2025, 5:16 PM EDT

Cadrenal Therapeutics Statistics

Total Valuation

CVKD has a market cap or net worth of $34.70 million. The enterprise value is $24.68 million.

Market Cap 34.70M
Enterprise Value 24.68M

Important Dates

The last earnings date was Thursday, March 13, 2025, after market close.

Earnings Date Mar 13, 2025
Ex-Dividend Date n/a

Share Statistics

CVKD has 1.88 million shares outstanding. The number of shares has increased by 35.59% in one year.

Current Share Class 1.88M
Shares Outstanding 1.88M
Shares Change (YoY) +35.59%
Shares Change (QoQ) +48.53%
Owned by Insiders (%) 30.69%
Owned by Institutions (%) 7.02%
Float 1.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.42
P/TBV Ratio 4.66
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.77

Current Ratio 3.77
Quick Ratio 3.75
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -140.78% and return on invested capital (ROIC) is -90.41%.

Return on Equity (ROE) -140.78%
Return on Assets (ROA) -73.49%
Return on Invested Capital (ROIC) -90.41%
Return on Capital Employed (ROCE) -147.33%
Revenue Per Employee n/a
Profits Per Employee -$2.66M
Employee Count 4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +92.29% in the last 52 weeks. The beta is 1.45, so CVKD's price volatility has been higher than the market average.

Beta (5Y) 1.45
52-Week Price Change +92.29%
50-Day Moving Average 18.77
200-Day Moving Average 13.08
Relative Strength Index (RSI) 48.89
Average Volume (20 Days) 37,294

Short Selling Information

The latest short interest is 41,482, so 2.21% of the outstanding shares have been sold short.

Short Interest 41,482
Short Previous Month 29,065
Short % of Shares Out 2.21%
Short % of Float 3.18%
Short Ratio (days to cover) 1.10

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -10.96M
Pretax Income -6.24M
Net Income -10.65M
EBITDA -10.96M
EBIT -10.96M
Earnings Per Share (EPS) -$8.73
Full Income Statement

Balance Sheet

The company has $10.02 million in cash and n/a in debt, giving a net cash position of $10.02 million or $5.33 per share.

Cash & Cash Equivalents 10.02M
Total Debt n/a
Net Cash 10.02M
Net Cash Per Share $5.33
Equity (Book Value) 7.44M
Book Value Per Share 4.17
Working Capital 7.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.36 million and capital expenditures -$6,537, giving a free cash flow of -$7.36 million.

Operating Cash Flow -7.36M
Capital Expenditures -6,537
Free Cash Flow -7.36M
FCF Per Share -$3.92
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -35.59%
Shareholder Yield -35.59%
Earnings Yield -30.70%
FCF Yield -21.22%

Analyst Forecast

The average price target for CVKD is $32.00, which is 73.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target $32.00
Price Target Difference 73.35%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -29.54%
Stock Forecasts

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Aug 20, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1